Your browser doesn't support javascript.
loading
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.
Mehnert, Janice M; Varga, Andrea; Brose, Marcia S; Aggarwal, Rahul R; Lin, Chia-Chi; Prawira, Amy; de Braud, Filippo; Tamura, Kenji; Doi, Toshihiko; Piha-Paul, Sarina A; Gilbert, Jill; Saraf, Sanatan; Thanigaimani, Pradeep; Cheng, Jonathan D; Keam, Bhumsuk.
Affiliation
  • Mehnert JM; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ, 08901, USA. mehnerja@cinj.rutgers.edu.
  • Varga A; Institut Gustave Roussy, 114, rue Edouard-Vaillant, 94800, Villejuif, France.
  • Brose MS; Department of Otorhinolaryngology, Head and Neck Surgery and the Abramson Cancer Center at the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA.
  • Aggarwal RR; University of California, San Francisco Cancer Center, 500 Parnassus Avenue, San Francisco, CA, 94143, USA.
  • Lin CC; Department of Oncology, National Taiwan University Hospital, 7 Chung-Shan S Rd, Taipei, 10002, Taiwan.
  • Prawira A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2C1, Canada.
  • de Braud F; Department of Oncology, University of Milan and Fondazione IRCCS Istituto Nazionale Tumori Milano, Via Giacomo Venezian 1, 20133, Milan, Italy.
  • Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital Tokyo, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Doi T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Piha-Paul SA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Gilbert J; Hematology/Oncology, Vanderbilt University School of Medicine, 215 Light Hall, Nashville, TN, 37232, USA.
  • Saraf S; Merck & Co., Inc., 8000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
  • Thanigaimani P; Merck & Co., Inc., 8000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
  • Cheng JD; Merck & Co., Inc., 8000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, 101, Daehak-Ro, Jongno-Gu, Seoul, 03080, Republic of Korea.
BMC Cancer ; 19(1): 196, 2019 Mar 04.
Article in En | MEDLINE | ID: mdl-30832606
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma, Follicular / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Thyroid Cancer, Papillary Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma, Follicular / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Thyroid Cancer, Papillary Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: United States